Top

Cannvas Forms Education Advisory Panel and Adds A Master of Education

Cannvas Forms Education Advisory Panel and Adds A Master of Education

Education Fundamental to the Cannvas.me Platform

TORONTO, Aug. 15, 2018 /CNW/ – Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE: MTEC, Frankfurt: 3CM), a leading business technology company in the cannabis space, is pleased to announce the appointment of Elizabeth Moniz and Tom Loutskou to the newly formed Cannvas Education Advisory Panel. The Cannvas Education Advisory Panel will advise and set protocols for the broad educational spectrum that Cannvas.me offers to the medical cannabis industry.

“I am very pleased to welcome Elizabeth and Tom to the newly the formed Cannvas Education Advisory Panel,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. “The Education Advisory Panel will be made up of leading experts in the educational development field and instrumental in the way Cannvas.me delivers education to the medical cannabis world. Elizabeth (whose focus was Neuropsychology) and Tom (who has a Masters in Education) bring extensive education and training experience to our online medical cannabis platform. I look forward to working with the Panel as we roll out a robust medical cannabis educational program with the Cannvas.me platform.”

Cannvas.me is a scalable and comprehensive solution for the global medical cannabis community offering interactive tools and physician-backed content to audiences wishing to learn about healthcare through cannabis. Its Cannvas Academy, already guided by its Medical Advisory Board, will receive additional oversight and direction from the Education Advisory Panel, made up of highly qualified members from industry and government institutions.

A 20-year veteran in the education field as a teacher, mentor, and workshop leader, Elizabeth Moniz has extensive experience in health education. Through intensive research and relatable lesson plans, Elizabeth has helped hundreds of students thoroughly understand the implications of using a variety of substances. Elizabeth believes science-based information empowers people with the education needed to make healthy living choices. Elizabeth has an Honours Bachelor of Science Degree and a Post-Graduate Degree in Child Studies from the Ontario Institute for Studies in Education at the University of Toronto.

Tom Loutskou brings 17 years of teaching experience with a focus on physical and health education.  A vocal supporter of medicinal cannabis use for pain management and treatment of other ailments, Tom graduated from York University with an Honours Bachelor of Science with Majors in Kinesiology and Biology and a Bachelor of Education, and holds a Masters of Education from Nipissing University.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

SOURCE Cannvas MedTech Inc.

Cannvas MedTech Inc. (CNW Group/Cannvas MedTech Inc.)

For further information: www.cannvasmedtech.com; Media Inquiries: media@cannvasmedtech.com; Investor Relations: ir@cannvasmedtech.com, 1-800-489-0116

X